Abiomed Heart Patient Taken Off Life Support, Dies
Mon May 17, 4:11 PM ET
NEW YORK (Reuters) - Abiomed Inc. said on Monday the 12th patient treated with its experimental artificial heart was removed from life support at the request of his family and died.
The 63-year-old man, treated at the Texas Heart Institute, survived 85 days on the grapefruit-sized plastic and titanium replacement heart, known as Abiocor.
The company said the patient died on May 16 when the family removed him from life support. They made the decision because of unrecoverable liver and kidney failure, conditions that predated treatment with the device.
To qualify for the Abiocor trial, patients had to be gravely ill with less than 30 days to live and could not be candidates for a heart transplant.
The company said the patient experienced no stroke, device malfunction or other significant complications related to the device.
A 13th patient was implanted with the heart on May 3, at Jewish Hospital in Louisville. The company was not immediately available to confirm the number of patients surviving with its artificial heart.
Shares of Abiomed fell 31 cents, or nearly 3 percent, to close at $10.89 on Monday on the New York Stock Exchange.